| Issue Type | XXXX |
|---|---|
| Country | Singapore |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2026-05-19 |
| Par Value | 0 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 0.00 |
| Coupon | 4.45 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 3000.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Pfizer Investment Enterprises Pte. Ltd corporate note has a X.X % fixed rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million USD and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
Pfizer Investment Enterprises Pte. Ltd, founded in Singapore, operates as a wholly-owned subsidiary of Pfizer Inc., focusing on strategic investments to support the global pharmaceutical development and commercialization efforts of its parent company. The firm specializes in offering financing solutions and managing treasury functions in line with Pfizer's corporate objectives, thereby enhancing liquidity and capital structure efficiency.